EFFICACY OF INCOBOTULINUMTOXINA IN THE TREATMENT OF 6-TO 17-YEAR-OLD CHILDREN AND ADOLESCENTS WITH CHRONIC SIALORRHEA ASSOCIATED WITH NEUROLOGICAL DISORDERS AND/OR INTELLECTUAL DISABILITY

被引:0
|
作者
Berweck, Steffen [1 ,2 ]
Kim, Heakyung [3 ]
Banach, Marta [4 ]
Hanschmann, Angelika [5 ]
Althaus, Michael [5 ]
Bonikowski, Marcin [6 ]
机构
[1] Schoen Klin Vogtareuth, Vogtareuth, Germany
[2] Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany
[3] Columbia Univ, Irving Med Ctr, New York Presbyterian Hosp, New York, NY USA
[4] Jagiellonian Univ, Krakow, Poland
[5] Merz Pharmaceut GmbH, Frankfurt, Germany
[6] Mazovian Neuropsychiat Ctr, Warsaw, Poland
关键词
Botulinum neurotoxin type A; Chronic sialorrhea; IncobotulinumtoxinA; Pediatric;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S7 / S8
页数:2
相关论文
共 12 条
  • [1] SAFETY OF INCOBOTULINUMTOXIN/A IN THE TREATMENT OF 6-TO 17-YEAR-OLD CHILDREN AND ADOLESCENTS WITH CHRONIC SIALORRHEA ASSOCIATED WITH NEUROLOGICAL DISORDERS AND/OR INTELLECTUAL DISABILITY
    Berweck, Steffen
    Bonikowski, Marcin
    Kim, Heakyung
    Hanschmann, Angelika
    Althaus, Michael
    Banach, Marta
    [J]. TOXICON, 2021, 190 : S8 - S8
  • [2] EFFICACY AND SAFETY OF INCOBOTULINUMTOXIN/A IN THE TREATMENT OF 2-TO 5-YEAR-OLD CHILDREN WITH CHRONIC SIALORRHEA ASSOCIATED WITH NEUROLOGICAL DISORDERS AND/OR INTELLECTUAL DISABILITY
    Berweck, Steffen
    Bonikowski, Marcin
    Banach, Marta
    Hanschmann, Angelika
    Althaus, Michael
    Kim, Heakyung
    [J]. TOXICON, 2021, 190 : S8 - S9
  • [3] Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders
    Berweck, S.
    Kim, H.
    Banach, M.
    Hanschmann, A.
    Althaus, M.
    Bonikowski, M.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S126 - S126
  • [4] A study on health and the association between overweight/obesity and otorhinolaryngological diseases in 6-to 17-year-old children from Wroclaw, Poland
    Zatonski, Tomasz
    Pazdro-Zastawny, Katarzyna
    Kolator, Mateusz
    Krajewska, Joanna
    Basiak-Rasala, Alicja
    Gorna, Sara
    Zatonski, Michal
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (02) : 413 - 421
  • [6] Aetiology of severe mental retardation and further genetic analysis by high-resolution microarray in a population-based series of 6-to 17-year-old children
    Lundvall, Mikael
    Rajaei, Saideh
    Erlandson, Anna
    Kyllerman, Marten
    [J]. ACTA PAEDIATRICA, 2012, 101 (01) : 85 - 91
  • [7] Can the Chinese study on the normal range of FeNO in children evaluate standardized asthma treatment efficacy in 6-to 12-year-old children?
    Yang, Qiuyan
    Cai, Chunling
    Xu, Qingrong
    Zheng, Yuehong
    Li, Aijun
    Liu, Ying
    Li, Shufang
    Zhang, Yanli
    [J]. FRONTIERS IN PEDIATRICS, 2023, 11
  • [8] Injury risks in schoolchildren with attention-deficit/hyperactivity or autism spectrum disorder: Results from two school-based health surveys of 6-to 17-year-old children in Sweden
    Bonander, Carl
    Beckman, Linda
    Janson, Staffan
    Jernbro, Carolina
    [J]. JOURNAL OF SAFETY RESEARCH, 2016, 58 : 49 - 56
  • [9] Efficacy and Safety of Fixed-Dose Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder in Children and Adolescents (6-17 years)
    Lewis, D. W.
    Couch, D. M.
    Marcus, R. N.
    Manos, G.
    Mankoski, R.
    Carson, W. H.
    McQuade, R. D.
    Owen, R.
    [J]. ANNALS OF NEUROLOGY, 2009, 66 : S110 - S110
  • [10] Efficacy and Safety of Flexibly-dosed Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder in Children and Adolescents (6-17 years)
    Lewis, D. W.
    Couch, D. M.
    Marcus, R. N.
    Manos, G.
    Mankoski, R.
    Carson, W. H.
    McQuade, R. D.
    Owen, R.
    [J]. ANNALS OF NEUROLOGY, 2009, 66 : S110 - S111